Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre

European Journal of Endocrinology

Volumn 150, Issue 4, 2004, Pages 439-445

  Bonnema, Steen J ^a   Nielsen, Viveque E ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; ECHOGRAPHY; ESTHETICS; FEMALE; FOLLOW UP; GOITER; HUMAN; HYPOTHYROIDISM; LONG TERM CARE; MALE; NECK PAIN; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOMATOLOGY; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID WEIGHT; THYROIDECTOMY; THYROIDITIS; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GOITER, ENDEMIC; HUMANS; HYPOTHYROIDISM; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; THYROID GLAND;

EID: 2342586081     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500439     Document Type: Article

References (28)

1. Perrild H, Hansen JM, Hegedüs L, Rytter L, Holm B, Gundtofte E & Johansen K. Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinologica 1982 100 382-387.
2. 3-compound preparation in the treatment of diffuse endemic goitre. Acta Endocrinologica 1986 113 242-248.
3. Hansen JM, Kampmann J, Madsen SN, Skovsted L, Solgaard S, Grytter C, Grontvedt T & Rasmussen SN. L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clinical Endocrinology 1979 10 1-6.
4. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ & Touber JL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990 336 193-197.
5. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865.
6. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP & Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 1996 81 4278-4289.
7. al Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M & Graversen HP. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. European Journal of Surgery 1997 163 13-20.
8. de Klerk JM, Van Isselt JW, van Dijk A, Hakman ME, Pameijer FA, Koppeschaar HP et al. Iodine-131 therapy in sporadic nontoxic goiter. Journal of Nuclear Medicine 1997 38 372-376.
9. Le Moli R, Wesche MF, Tiel-Van Buul MM & Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non- toxic goitre. Clinical Endocrinology 1999 50 783-789.
10. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P & Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. British Medical Journal 1993 307 828-832.
11. Wesche MF, Tiel-Van Buul MM, Lips P, Smits NJ & Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. Journal of Clinical Endocrinology and Metabolism 2001 86 998-1005.
12. Kok SW, Smit JW, de Craen AJ, Goslings BM, Eck-Smit BL & Romijn JA. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study. Nuclear Medicine Communications 2000 21 1071-1078.
13. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC & Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 978-983.
14. Jarløv AE, Hegedüs L, Kristensen LO, Nygaard B & Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clinical Endocrinology 1995 43 325-329.
15. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G & Hansen JM. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. Journal of Clinical Endocrinology and Metabolism 1983 56 260-263.
16. Knudsen N, Bülow I, Jørgensen T, Laurberg P, Ovesen L & Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clinical Endocrinology 2000 53 479-485.
17. Hegedüs L, & Bennedbæk FN. Radioiodine for non-toxic diffuse goitre. Lancet 1997 350 409-410.
18. Nygaard B, Faber J, Veje A & Hansen JE. Thyroid volume and function after 131I treatment of diffuse non-toxic goitre. Clinical Endocrinology 1997 46 493-496.
19. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L & Hegedüs L. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. Journal of Clinical Endocrinology and Metabolism 1999 84 3636-3641.
20. Huysmans DA, Hermus AR, Corstens FH, Barentsz JO & Kloppenborg PW. Large, compressive goiters treated with radioiodine. Annals of Internal Medicine 1994 121 757-762.
21. Berghout A, Wiersinga WM, Smits NJ & Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. American Journal of Medicine 1990 89 602-608.
22. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Hansen BM, Søe-Jensen P & Hansen JM. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. Journal of Internal Medicine 1995 238 491-497.
23. Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG & Hansen JM. Radioiodine therapy for multinodular toxic goiter. Archives of Internal Medicine 1999 159 1364-1368.
24. Bonnema SJ, Bennedbæk FN, Wiersinga WM & Hegedüs L. Management of the nontoxic multinodular goitre: a European questionnaire study. Clinical Endocrinology 2000 53 5-12.
25. Bonnema SJ, Bennedbæk FN, Ladenson PW & Hegedüs L. Management of the nontoxic multinodular goiter: A North American Survey. Journal of Clinical Endocrinology and Metabolism 2002 87 112-117.
26. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J & Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999 353 2111-2115.
27. Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. International Journal of Cancer 1992 50 886-890.
28. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998 280 347-355.